US30050B1017 - Common Stock
"In 2024, we expect to eclipse $1 billion in revenue and deliver our first full year of net income profitability.": CEO Andrew Dudum
Learn about the financial offering of Evolent Health (EVH) as they file a prospectus for the sale of securities in this informative article by our financial...
EVH earnings call for the period ending December 31, 2023.
Evolent Health's strong Q4 results showcase higher earnings per share and exceed revenue expectations, reflecting a significant year-over-year growth.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
Engaged Capital, a hedge fund, reveals its new stakes and increased positions in various companies, while reducing its holding in another.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
Evolent Health prices $350M convertible senior notes due 2029, with interest payable semiannually.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
Evolent Health plans to raise $350M through convertible senior notes.
Piper Sandler said it would be buyers of Evolent Health (EVH), Omnicell (OMCL) and Health Catalyst (HCAT) moving into 2024 and its annual healthcare conference
EVH earnings call for the period ending September 30, 2023.
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
EVH earnings call for the period ending June 30, 2023.
Evolent Health press release (EVH): Q2 Non-GAAP EPS of $0.14 misses by $0.01.Revenue of $469.1M (+46.6% Y/Y) beats by $8.46M.For the three months ending September 30, 2023, revenue...
/PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven...
/PRNewswire/ -- Evolent Health Inc. (NYSE: EVH), a health care company that delivers proven value-based specialty care solutions to payers and providers,...